Oct 23 (Reuters) – Bristol Myers Squibb on Friday disclosed a patient death in an early-stage trial studying its experimental CAR T cell therapy.
Shares of the drugmaker were trading 2.5% lower in early trading.
(Reporting by Sriparna Roy in Bengaluru; Editing by Shinjini Ganguli)
Brought to you by www.srnnews.com
SRN News — View the original story at SRNNews.com.
